300869 康泰医学
等待开盘 07-17 09:30:00
资讯
新帖
简况
康泰医学(300869.SZ)获“心电及电生理网络管理系统软件”医疗器械注册证
智通财经 · 07-11
康泰医学(300869.SZ)获“心电及电生理网络管理系统软件”医疗器械注册证
康泰医学新注册《康泰CONTEC100A超声骨密度仪嵌入式软件V1.0》项目的软件著作权
证券之星 · 07-01
康泰医学新注册《康泰CONTEC100A超声骨密度仪嵌入式软件V1.0》项目的软件著作权
康泰医学新注册《康泰优贝应用软件(Android版)V1.0.0》项目的软件著作权
证券之星 · 06-23
康泰医学新注册《康泰优贝应用软件(Android版)V1.0.0》项目的软件著作权
康泰医学最新公告:公司医疗器械产品获得美国FDA批准函
证券之星 · 06-21
康泰医学最新公告:公司医疗器械产品获得美国FDA批准函
康泰医学(300869.SZ):超声多普勒胎儿心率仪获美国FDA批准函
智通财经 · 06-21
康泰医学(300869.SZ):超声多普勒胎儿心率仪获美国FDA批准函
康泰医学新注册《康泰R100单水平正压通气治疗机嵌入式软件V1.0》项目的软件著作权
证券之星 · 06-21
康泰医学新注册《康泰R100单水平正压通气治疗机嵌入式软件V1.0》项目的软件著作权
6月6日康泰医学跌5.27%,大成中证1000指数增强发起式A基金重仓该股
证券之星 · 06-06
6月6日康泰医学跌5.27%,大成中证1000指数增强发起式A基金重仓该股
康泰医学:如有相关计划,公司会按照规定及时履行信息披露义务
证券之星 · 06-05
康泰医学:如有相关计划,公司会按照规定及时履行信息披露义务
康泰医学获得外观设计专利授权:“血脂检测仪”
证券之星 · 05-24
康泰医学获得外观设计专利授权:“血脂检测仪”
康泰医学:公司本次可转债转股价格调整是基于分红的基础上进行的价格调整,是正常的除权除息行为
证券之星 · 05-23
康泰医学:公司本次可转债转股价格调整是基于分红的基础上进行的价格调整,是正常的除权除息行为
康泰医学(300869.SZ)拟10股派3元 于5月29日除权除息
智通财经 · 05-21
康泰医学(300869.SZ)拟10股派3元 于5月29日除权除息
康泰医学:将于5月17日下午举行2023年度业绩说明会
中国财富通 · 05-14
康泰医学:将于5月17日下午举行2023年度业绩说明会
康泰医学:2023年一季度市场需求激增,公司营业收入及净利润实现增长
证券之星 · 05-08
康泰医学:2023年一季度市场需求激增,公司营业收入及净利润实现增长
康泰医学:2023年一季度市场需求激增,销售额及利润实现增长
证券之星 · 05-06
康泰医学:2023年一季度市场需求激增,销售额及利润实现增长
康泰医学(300869.SZ)子公司取得一项医疗器械注册证
智通财经 · 05-06
康泰医学(300869.SZ)子公司取得一项医疗器械注册证
康泰医学(300869.SZ)两项产品取得美国FDA批准函
智通财经 · 05-06
康泰医学(300869.SZ)两项产品取得美国FDA批准函
图解康泰医学一季报:第一季度单季净利润同比减97.44%
证券之星 · 04-28
图解康泰医学一季报:第一季度单季净利润同比减97.44%
康泰医学(300869.SZ)发布一季度业绩,净利润435.19万元,下降97.44%
智通财经网 · 04-28
康泰医学(300869.SZ)发布一季度业绩,净利润435.19万元,下降97.44%
康泰医学(300869)2023年年报简析:增收不增利,三费占比上升明显
证券之星 · 04-26
康泰医学(300869)2023年年报简析:增收不增利,三费占比上升明显
康泰医学获得外观设计专利授权:“电动吸奶器”
证券之星 · 04-26
康泰医学获得外观设计专利授权:“电动吸奶器”
加载更多
公司概况
公司名称:
康泰医学系统(秦皇岛)股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-08-24
主营业务:
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。
发行价格:
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":12.78,"timestamp":1721179743000,"preClose":12.78,"halted":0,"volume":0,"delay":0,"floatShares":252000000,"shares":401999999,"eps":0.0002,"marketStatus":"等待开盘","marketStatusCode":7,"change":0,"latestTime":"07-17 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":12.89,"askSize":20,"bidPrice":12.77,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.0002,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721179800000},"adr":0,"adjPreClose":12.78,"symbolType":"stock","openAndCloseTimeList":[[1721179800000,1721187000000],[1721192400000,1721199600000]],"highLimit":14.06,"lowLimit":11.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401802765,"pbRate":2.54,"roa":"--","roe":"0.21%","epsLYR":0.41,"committee":-0.326923,"marketValue":5135000000,"floatMarketCap":3215000000,"peRate":63900.001614,"changeRate":0,"turnoverRate":0,"status":2},"requestUrl":"/m/hq/s/300869","defaultTab":"news","newsList":[{"id":"2450333663","title":"康泰医学(300869.SZ)获“心电及电生理网络管理系统软件”医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2450333663","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450333663?lang=zh_cn&edition=full","pubTime":"2024-07-11 16:39","pubTimestamp":1720687154,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司于今日取得了由河北省药品监督管理局颁发的《中华人民共和国医疗器械注册证》,产品名称:心电及电生理网络管理系统软件。该产品适用于医院心电及电生理数据的数字化管理,可实现对数据的显示、生成报告、统计、检索,并通过网络实现院内科室间或医联体院间的数据与报告的传输以及院内报告共享。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","09997","BK1100","BK1574","BK1222","09996","BK0251","159883","BK1583"],"gpt_icon":0},{"id":"2448183602","title":"康泰医学新注册《康泰CONTEC100A超声骨密度仪嵌入式软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2448183602","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448183602?lang=zh_cn&edition=full","pubTime":"2024-07-01 01:15","pubTimestamp":1719767737,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了《康泰CONTEC100A超声骨密度仪嵌入式软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权10个,较去年同期增加了900%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1.11亿元,同比增18.6%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100000837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2445725777","title":"康泰医学新注册《康泰优贝应用软件(Android版)V1.0.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2445725777","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445725777?lang=zh_cn&edition=full","pubTime":"2024-06-23 01:00","pubTimestamp":1719075632,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了《康泰优贝应用软件(Android版)V1.0.0》项目的软件著作权。今年以来康泰医学新注册软件著作权8个,较去年同期增加了700%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1.11亿元,同比增18.6%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062300000035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2445732275","title":"康泰医学最新公告:公司医疗器械产品获得美国FDA批准函","url":"https://stock-news.laohu8.com/highlight/detail?id=2445732275","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445732275?lang=zh_cn&edition=full","pubTime":"2024-06-21 18:09","pubTimestamp":1718964581,"startTime":"0","endTime":"0","summary":"康泰医学公告,近日,公司收到美国食品药品监督管理局签发的实质等同批准函,公司产品型号为CONTEC 10D、CONTEC 10E和CONTEC 10F的Pocket Fetal Doppler已通过FDA的510实质等同批准,510号码为K232893。公司上述产品获得美国FDA审核批准函后,标志着该型号产品允许在美国合法销售,公司海外销售产品品类得到进一步扩充,增强了公司的综合竞争力,对公司产品在国际市场的销售将起到推动作用。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100040870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","159883","BK0251","BK1583","09997","BK1574","300869","BK1100","09996"],"gpt_icon":0},{"id":"2445734749","title":"康泰医学(300869.SZ):超声多普勒胎儿心率仪获美国FDA批准函","url":"https://stock-news.laohu8.com/highlight/detail?id=2445734749","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445734749?lang=zh_cn&edition=full","pubTime":"2024-06-21 18:02","pubTimestamp":1718964141,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司收到美国食品药品监督管理局(简称“FDA”)签发的实质等同批准函。公司产品型号为CONTEC 10D、CONTEC 10E 和 CONTEC 10F 的 Pocket Fetal Doppler(中文翻译:超声多普勒胎儿心率仪)已通过FDA的510(K)实质等同批准,510(K)号码为K232893。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1138689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2445247621","title":"康泰医学新注册《康泰R100单水平正压通气治疗机嵌入式软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2445247621","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445247621?lang=zh_cn&edition=full","pubTime":"2024-06-21 01:28","pubTimestamp":1718904507,"startTime":"0","endTime":"0","summary":"证券之星消息,近日康泰医学(300869)新注册了《康泰R100单水平正压通气治疗机嵌入式软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权7个,较去年同期增加了600%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1.11亿元,同比增18.6%。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100002105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2441176009","title":"6月6日康泰医学跌5.27%,大成中证1000指数增强发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441176009","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441176009?lang=zh_cn&edition=full","pubTime":"2024-06-06 16:41","pubTimestamp":1717663272,"startTime":"0","endTime":"0","summary":"证券之星消息,6月6日康泰医学跌5.27%创60日新低,收盘报13.83元,换手率1.42%,成交量3.56万手,成交额5020.28万元。重仓康泰医学的公募基金请见下表:根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为大成中证1000指数增强发起式A。大成中证1000指数增强发起式A目前规模为0.89亿元,最新净值0.8553,较上一交易日下跌1.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060600032390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869","159845","000001.SH","399852","000852.SH"],"gpt_icon":0},{"id":"2441522141","title":"康泰医学:如有相关计划,公司会按照规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2441522141","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441522141?lang=zh_cn&edition=full","pubTime":"2024-06-05 19:02","pubTimestamp":1717585337,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学(300869)06月05日在投资者关系平台上答复投资者关心的问题。投资者:公司股东和实控人是否有增持计划?康泰医学董秘:尊敬的投资者您好,如有相关计划,公司会按照规定及时履行信息披露义务。感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500037096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2437791541","title":"康泰医学获得外观设计专利授权:“血脂检测仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2437791541","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437791541?lang=zh_cn&edition=full","pubTime":"2024-05-24 02:06","pubTimestamp":1716487572,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示康泰医学新获得一项外观设计专利授权,专利名为“血脂检测仪”,专利申请号为CN202330605441.4,授权日为2024年5月24日。专利摘要:1.本外观设计产品的名称:血脂检测仪。今年以来康泰医学新获得专利授权20个,较去年同期减少了33.33%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1.11亿元,同比增18.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400002638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2437736301","title":"康泰医学:公司本次可转债转股价格调整是基于分红的基础上进行的价格调整,是正常的除权除息行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2437736301","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437736301?lang=zh_cn&edition=full","pubTime":"2024-05-23 18:04","pubTimestamp":1716458658,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学05月23日在投资者关系平台上答复投资者关心的问题。请您百忙中予以回复,谢谢康泰医学董秘:尊敬的投资者您好,公司本次可转债转股价格调整是基于分红的基础上进行的价格调整,是正常的除权除息行为。关于对外合作事项,公司始终持开放态度,在深耕主营业务的基础上,公司将围绕发展战略及规划,积极寻求与优秀企业合作的机会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052300033398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2437418451","title":"康泰医学(300869.SZ)拟10股派3元 于5月29日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2437418451","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437418451?lang=zh_cn&edition=full","pubTime":"2024-05-21 18:54","pubTimestamp":1716288863,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司2023年年度权益分派拟:向全体股东每10股派3.00元。除权除息日为:2024年5月29日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1124036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2435560132","title":"康泰医学:将于5月17日下午举行2023年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2435560132","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435560132?lang=zh_cn&edition=full","pubTime":"2024-05-14 17:22","pubTimestamp":1715678562,"startTime":"0","endTime":"0","summary":"中国财富通5月14日 - 康泰医学(300869)公告称,为使投资者进一步了解公司的财务状况、经营情况及公司发展规划,公司将于5月17日(星期五)15:30-16:30在全景网举行2023年度业绩说明会。出席本次业绩说明会的人员有:董事长胡坤,董事、总经理杨志山,董事、董事会秘书、财务总监郑敏,独立董事李华,保荐代表人孙泉。因工作安排或其他要求,如遇特殊情况,参加人员可能进行调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=g1vH6tKjC2E%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2433743417","title":"康泰医学:2023年一季度市场需求激增,公司营业收入及净利润实现增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2433743417","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433743417?lang=zh_cn&edition=full","pubTime":"2024-05-08 18:04","pubTimestamp":1715162663,"startTime":"0","endTime":"0","summary":"康泰医学董秘:尊敬的投资者您好,北美地区是公司主要销售区域之一,截至2023年底,公司已获得21张美国FDA批准函,数十款产品获准在北美地区市场上市销售。上述产品FDA批准函的获得,有利于丰富公司海外销售产品品类,对公司的海外销售业务将起到推动作用。康泰医学董秘:尊敬的投资者您好,2023年一季度市场需求激增,公司营业收入及净利润实现增长。2024年一季度受部分产品需求下降、行业消化库存等因素影响,当期收入减少,利润下滑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800032113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2433422368","title":"康泰医学:2023年一季度市场需求激增,销售额及利润实现增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2433422368","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433422368?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:01","pubTimestamp":1714996873,"startTime":"0","endTime":"0","summary":"投资者:董秘你好,已经披露公告显示,贵公司仅仅2023年一季度实现业绩大幅增长,随后几个季度出现断崖式回落,年报出现较2022年同比下降!康泰医学董秘:尊敬的投资者您好,2023年一季度市场需求激增,销售额及利润实现增长。2024年一季度受部分产品需求下降、行业消化库存等因素影响,当期收入减少,利润下滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600024313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2433423038","title":"康泰医学(300869.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2433423038","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433423038?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:56","pubTimestamp":1714992960,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司全资子公司长沙康泰医芯生物科技有限责任公司于近日收到由湖南省药品监督管理局颁发的《医疗器械注册证》,产品名称为:全瓷义齿用氧化锆瓷块及染色液。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK1222","300869","BK1583","09997","159883","BK1574","BK1100","09996"],"gpt_icon":0},{"id":"2433752423","title":"康泰医学(300869.SZ)两项产品取得美国FDA批准函","url":"https://stock-news.laohu8.com/highlight/detail?id=2433752423","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433752423?lang=zh_cn&edition=full","pubTime":"2024-05-06 18:53","pubTimestamp":1714992822,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)公告,公司收到美 国食品药品监督管理局(“FDA”)签发的实质等同批准函。公司产品Color Doppler Ultrasound Diagnostic System 彩色多普勒超声诊断系统 (CMS1700B,CMS1700C)和B-Ultrasound Diagnostic System B 型超声诊断设备 (CMS600P2PLUS)已通过FDA 的510(K)实质等同批准。510(K)号码分别为K232908、K232895。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2430031035","title":"图解康泰医学一季报:第一季度单季净利润同比减97.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430031035","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430031035?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:46","pubTimestamp":1714297561,"startTime":"0","endTime":"0","summary":"证券之星消息,康泰医学2024年一季报显示,公司主营收入9917.52万元,同比下降73.1%;归母净利润435.19万元,同比下降97.44%;扣非净利润-331.65万元,同比下降102.02%;负债率33.87%,投资收益769.58万元,财务费用-492.64万元,毛利率49.39%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800006456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2430087188","title":"康泰医学(300869.SZ)发布一季度业绩,净利润435.19万元,下降97.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430087188","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430087188?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:03","pubTimestamp":1714291386,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康泰医学(300869.SZ)发布2024年第一季度报告,该公司营业收入为9917.52万元,同比减少73.10%。归属于上市公司股东的净利润为435.19万元,同比减少97.44%。归属于上市公司股东的扣除非经常性损益的净亏损为331.65万元。基本每股收益为0.0108元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300869"],"gpt_icon":0},{"id":"2430263113","title":"康泰医学(300869)2023年年报简析:增收不增利,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2430263113","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430263113?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:28","pubTimestamp":1714084106,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期康泰医学发布2023年年报。根据财报显示,本报告期中康泰医学增收不增利,三费占比上升明显。截至本报告期末,公司营业总收入7.47亿元,同比上升4.89%,归母净利润1.66亿元,同比下降15.51%。财务费用变动幅度为38.64%,原因:公司于2022年7月发行了可转换公司债券,上年可转债实际计息期为6个月,本报告期可转债实际计息期为12个月,导致利息支出较去年增加1,615万元。报告期内定期存款利息收入较上年减少309万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600013961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2430025822","title":"康泰医学获得外观设计专利授权:“电动吸奶器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2430025822","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430025822?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:40","pubTimestamp":1714070415,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示康泰医学新获得一项外观设计专利授权,专利名为“电动吸奶器”,专利申请号为CN202330605448.6,授权日为2024年4月26日。专利摘要:1.本外观设计产品的名称:电动吸奶器。今年以来康泰医学新获得专利授权13个,较去年同期减少了18.75%。结合公司2023年年报财务数据,2023年公司在研发方面投入了1.11亿元,同比增18.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600004555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","stockEarnings":[{"period":"1week","weight":0.0151},{"period":"1month","weight":-0.0871},{"period":"3month","weight":-0.1776},{"period":"6month","weight":-0.3221},{"period":"1year","weight":-0.4288},{"period":"ytd","weight":-0.3681}],"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","perCapita":"6656股","boardName":"专用设备制造业","registeredCapital":"40180万元","compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.031},{"period":"6month","weight":0.0459},{"period":"1year","weight":-0.0727},{"period":"ytd","weight":0.0005}],"survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。产品涵盖血氧类、心电类、超声类、监护类、血压类等多个大类,建立了完善的研发、生产和销售体系。2023年4月,公司Remoltar远程专业彩色多普勒超声诊断系统荣获德国IF设计奖和意大利A设计奖。2023年10月,公司的儿童红外体温计产品斩获2023年广交会设计创新奖银奖,呼吸训练器、动态心电监护仪两款产品斩获铜奖。","serverTime":1721179759529,"listedPrice":10.16,"stockholders":"37793人(较上一季度减少3.40%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}